Last Updated: November 8, 2026

GLEOLAN Drug Patent Profile

Name: GLEOLAN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Gleolan patents expire, and when can generic versions of Gleolan launch?

Gleolan is a drug marketed by Nxdc and is included in one NDA.

The generic ingredient in GLEOLAN is aminolevulinic acid hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the aminolevulinic acid hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for GLEOLAN?
What are the global sales for GLEOLAN?
What is Average Wholesale Price for GLEOLAN?

Summary for GLEOLAN

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	117
Clinical Trials:	5
Patent Applications:	587
Drug Prices:	Drug price information for GLEOLAN
What excipients (inactive ingredients) are in GLEOLAN?	GLEOLAN excipients list
DailyMed Link:	GLEOLAN at DailyMed

Drug patent expirations by year for GLEOLAN

Recent Clinical Trials for GLEOLAN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
NX Development Corp	PHASE2
StacheStrong Foundation	PHASE2
Neuroscience Research Foundation	PHASE2

See all GLEOLAN clinical trials

Pharmacology for GLEOLAN

Drug Class	Optical Imaging Agent Porphyrin Precursor
Mechanism of Action	Fluorescence Contrast Activity

US Patents and Regulatory Information for GLEOLAN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nxdc	GLEOLAN	aminolevulinic acid hydrochloride	FOR SOLUTION;ORAL	208630-001	Jun 6, 2017		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.